Nuclear Medicine: Radiopharmaceuticals Needed

Add to your list(s) Download to your calendar using vCal

• Professor Wendy Galbraith, University of Oklahoma
• Thursday 30 May 2013, 16:30-18:00
• Cambridge University Engineering Department, Lecture Room 3B.

If you have a question about this talk, please contact Jo Boyle.

The use of radionuclides produced from nuclear reactors has become ingrained in the healthcare of patients. A supply issue in 2010 brought the world to a critical realization about the future of nuclear medicine. During times of supply issues, some patients will not receive key medical procedures and for the most urgent patients it’s a matter of life and death. Currently, the oldest medical reactors produce most of the world’s supply. The manufacturing and infrastructure requirements for producing specific isotopes will be discussed. We will also discuss how the production and shortage of one radionuclide, Molybdenum-99 (Mo-99), created long-term effects in the entire supply chain. Now is the new age for medical isotope production and it will take creativity and adaptability to ensure the viability of nuclear medicine.

This talk is part of the Engineering Department Nuclear Energy Seminars series.

This talk is included in these lists:

• Cambridge Energy Seminars
• Cambridge University Engineering Department, Lecture Room 3B
• NanoDTC Energy Materials Talks
• history

Note that ex-directory lists are not shown.